查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
自行注射器市場:現狀分析與預測(2022-2028年)
市場調查報告書
商品編碼
1290905

自行注射器市場:現狀分析與預測(2022-2028年)

Self-injection Devices Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 155 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於醫療保健領域越來越多地採用先進技術，預計自我注射器市場在預測期內將以 6% 的複合年增長率增長。例如，2022 年 5 月，Jabiru Healthcare 宣布推出 Qfinity(TM) 自動注射器平台，這是一種具有廣泛適用性的可重複使用的藥物輸送設備。

為了更好地了解自動注射器行業的市場採用情況，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、意大利、西班牙、歐洲其他地區） ）、亞太地區（中國、日本、印度）、韓國、澳大利亞以及亞太地區其他地區）以及世界其他地區。2021年，由於老年人口不斷增加以及老年人口疾病發生頻率增加，自動注射器市場由北美主導。此外，該地區主要市場參與者的存在和完善的醫療基礎設施歸因於北美自動注射器市場的主要佔有率。

目錄

第1章 市場簡介

  • 市場定義
  • 主要目的
  • 相關利益者
  • 限制事項

第2章 調查手法或前提

  • 調查流程
  • 調查手法
  • 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對全球自行注射器市場帶來的影響

第6章 全球自行注射器的市場收益，2020-2028年

第7章 市場洞察:各產品

  • 自動注射器
  • 筆型注射器
  • 穿戴式注射器
  • 無針注射器

第8章 市場洞察:各可用性

  • 拋棄式
  • 可重複使用

第9章 市場洞察:各用途

  • 癌症
  • 自體免疫疾病
  • 荷爾蒙障礙
  • 疼痛管理
  • 其他

第10章 市場洞察:各地區

  • 北美的自行注射器市場
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲的自行注射器市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區的自行注射器市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • APAC的其他各國
  • 其他地區的自行注射器市場

第11章 自行注射器市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第12章 自行注射器市場機會

第13章 自行注射器市場趨勢

第14章 需求面和供給面的分析

  • 需求面分析
  • 供給面分析

第15章 價值鏈分析

第16章 價格分析

第17章 策略性洞察能力

第18章 競爭模式

  • 競爭情形
    • 波特的五力分析

第19章 企業簡介

  • Ypsomed AG
  • BD
  • Gerresheimer AG
  • Halozyme, Inc.
  • Haselmeier
  • NuGen Medical Devices
  • Owen Mumford Limited
  • SHL Medical AG
  • Pfizer Inc.
  • Amgen Inc.

第20章 免責聲明

簡介目錄
Product Code: UMHE2118020

Self-injection devices are medical devices designed to allow patients to self-administer medications, such as insulin, growth hormones, and other biologics. These devices are typically used by patients who require regular injections and are designed to be easy to use, portable, and discreet. The growth of the market is mainly driven by the factors such as the increasing prevalence of chronic diseases requiring injectable treatments. For instance, as per the International Diabetes Federation, Approximately 537 million adults between 20 & 79 years are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

The Self-injection Devices Market is expected to grow at a strong CAGR of 6% during the forecast period owing to the increasing adoption of advanced technology in the healthcare sector. For instance, in May 2022, Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Reusable Drug Delivery Device with Broad Applicability.

Based on product, the market is segmented into autoinjectors, pen injectors, wearable injectors, and needle-free injectors. Pen injectors held dominating share in 2021. Pen injectors are medical devices that are used to deliver medication subcutaneously (under the skin) or intramuscularly (into the muscle). They consist of a pen-like device that contains a pre-filled cartridge or a replaceable insulin reservoir, and a needle that is attached to the end of the pen. The convenient usage of the self-injection of these devices, along with the increasing prevalence of chronic diseases attributes to the growth of the segment.

On the basis of usability, the market is bifurcated into disposable and reusable. The disposable segment held a significant share of the self-injection devices market in 2021. This is mainly due to the fact that disposable self-injection devices being sterile and designed for single use, which reduces the risk of infection or contamination. This is particularly important for patients who have compromised immune systems or are at higher risk for infection.

Based on application, the market is segmented into cancer, autoimmune disorders, hormonal disorders, pain management, and others. The cancer had the largest share in 2021 in the self-injection devices market. The higher prevalence of cancer is responsible for the increasing demand for self-injection devices. For instance, as per the National Cancer Institute, in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease.

For a better understanding of the market adoption of the self-injection devices industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America dominated the self-injection devices market in 2021 due to the rising geriatric population and increased frequency of diseases among them. Furthermore, the presence of major market players, along with the well-established healthcare infrastructure in the region attributed to the major share of the self-injection devices market in North America.

Some of the major players operating in the market include: Ypsomed AG; BD; Gerresheimer AG; Halozyme, Inc.; Haselmeier; NuGen Medical Devices; Owen Mumford Limited; SHL Medical AG; Pfizer Inc.; and Amgen Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Self-Injection Devices Market
  • 2.2. Research Methodology of the Self-Injection Devices Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL SELF-INJECTION DEVICES MARKET COVID-19 IMPACT

6 GLOBAL SELF-INJECTION DEVICES MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCTS

  • 7.1. Autoinjectors
  • 7.2. Pen injectors
  • 7.3. Wearable injectors
  • 7.4. Needle-free injectors

8 MARKET INSIGHTS BY USABILITY

  • 8.1. Disposable
  • 8.2. Reusable

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Cancer
  • 9.2. Autoimmune disorders
  • 9.3. Hormonal disorders
  • 9.4. Pain management
  • 9.5. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Self-Injection Devices Market
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Self-Injection Devices Market
    • 10.2.1. Germany
    • 10.2.2. UK
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific Self-Injection Devices Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of APAC
  • 10.4. Rest of the World Self-Injection Devices Market

11 SELF-INJECTION DEVICES MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 SELF-INJECTION DEVICES MARKET OPPORTUNITIES

13 SELF-INJECTION DEVICES MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1. Competitive Landscape
    • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

  • 19.1. Ypsomed AG
  • 19.2. BD
  • 19.3. Gerresheimer AG
  • 19.4. Halozyme, Inc.
  • 19.5. Haselmeier
  • 19.6. NuGen Medical Devices
  • 19.7. Owen Mumford Limited
  • 19.8. SHL Medical AG
  • 19.9. Pfizer Inc.
  • 19.10. Amgen Inc.

20 DISCLAIMER